| Patents for C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334) |
|---|
| 05/14/2003 | EP1310251A1 Antipruritic agent |
| 05/13/2003 | US6562835 One morphinan selected from the group consisting of dextromethorphan, dextrorphan and at least one active agent selected from tricyclic antidepressants, antispasmodics, direct-acting bladder smooth muscle relaxants, and estrogens |
| 05/07/2003 | EP0614898B1 Indole derivative, process for producing the same, and medicinal use thereof |
| 05/01/2003 | US20030083499 Pyridomorphinans and use thereof |
| 05/01/2003 | US20030083476 Morphine-6-glucuronide synthesis |
| 04/16/2003 | CN1105721C Process for preparing narcotic analgesics |
| 04/09/2003 | CN1408714A Novel oripavine derivative and its medical use |
| 04/02/2003 | EP0770081B1 Heterocycle-condensed morphinoid derivatives |
| 04/02/2003 | CN1407884A Controlled release hydrocodone formulations |
| 03/27/2003 | WO2003024972A1 New oripavine derivatives and their uses as medicines |
| 03/18/2003 | US6534514 Compound and selectively blocking the binding of a kappa opioid-receptor agonist to kappa opioid receptors in mammalian tissues |
| 03/18/2003 | US6534092 Method for preparing microparticles having a selected polymer molecular weight |
| 03/06/2003 | WO2003018588A2 Process for the preparation of a 14-hydroxynormorphinone derivative |
| 03/06/2003 | US20030045720 Mixing the narcotic alkaloid with an acid in the presence of a catalyst in the substantial absence of hydrogen gas |
| 02/27/2003 | WO2003015783A1 Method of treating alcoholism or alcohol abuse |
| 02/27/2003 | WO2002083135A3 Use of buprenorphine for the manufacture of a transdermal delivery device for the treatment of urinary incontinence, especially urge incontinence |
| 02/26/2003 | EP1285902A1 Method for labeling with tritium |
| 02/20/2003 | WO2003014122A1 Derivatives of morphine-like opioid compounds |
| 02/20/2003 | WO2002098427A3 Sustained-release analgesic compounds |
| 02/12/2003 | EP1282404A2 Method for preparing microparticles having a selected polymer molecular weight |
| 02/11/2003 | CA2154620C Method of detecting surface contamination by an analyte |
| 02/04/2003 | US6514773 Method of detecting surface contamination by an analyte |
| 01/30/2003 | WO2003007966A1 Active substance combination for medicamentous therapy of nicotine dependency |
| 01/30/2003 | US20030023104 For prolonging or altering the activity of a compound which is a member of the chlorambucil family |
| 01/30/2003 | US20030022876 Sustained-release analgesic compounds |
| 01/28/2003 | US6512117 Method of preparing a ketone from a narcotic alkaloid having an allyl alcohol moiety comprising: mixing the narcotic alkaloid with an acid in the presence of a catalyst wherein the method is carried out in the substantial absence of |
| 01/28/2003 | US6512115 Preparation of pigments |
| 12/19/2002 | US20020192277 Controlled release hydrocodone formulations |
| 12/18/2002 | EP0880526B1 Heterocycle-condensed morphinoid derivatives (ii) |
| 12/17/2002 | CA2095223C Topical compositions for transdermal delivery of prodrug derivatives of morphine |
| 12/12/2002 | WO2002098427A2 Sustained-release analgesic compounds |
| 12/12/2002 | CA2448665A1 Sustained-release analgesic compounds |
| 11/27/2002 | CN1382145A Remedies for neuropathic pain and model animals of neuropathic pain |
| 11/14/2002 | WO2002089845A1 Remedies for sepsis |
| 11/07/2002 | US20020165247 Use of morphine derivatives as medicaments for the treatment of neuropathic problems |
| 11/07/2002 | US20020164373 Opioid sustained-released formulation |
| 11/05/2002 | US6476044 Use of morphine derivatives as medicaments for the treatment of neuropathic problems |
| 10/31/2002 | WO2002043713A3 Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence |
| 10/24/2002 | WO2002083135A2 Use of buprenorphine for the manufacture of a transdermal delivery device for the treatment of urinary incontinence, especially urge incontinence |
| 10/22/2002 | US6469170 Method for preparing oxycodone |
| 10/17/2002 | WO2002081477A1 7-substituted morphinane derivatives and medicinal use thereof |
| 10/17/2002 | WO2002080918A1 Remedial or prophylactic agent for frequent urination or urinary incontinence |
| 10/17/2002 | WO2002070524A3 N-but-3-enyl norbuprenorphine and its use as analgesic |
| 10/16/2002 | CN1374963A Remedies or preventives for freqent urination or arinary incontinence |
| 10/15/2002 | US6465479 Pyridomorphinans and use thereof |
| 10/10/2002 | WO2002078744A1 Remedies for psychoneurosis |
| 10/03/2002 | US20020143183 Producing a dienol organosilyl ether at position 6 of the C-ring of codeinone thereby forming dienol organosilyl ether congener of codeinone; oxidizing dienol organosilyl ether to form 14-hydroxycodeinone; hydrogenating to produce oxycodone |
| 10/02/2002 | EP1244448A2 Novel methods for the treatment and prevention of ileus |
| 10/02/2002 | EP1086114B1 Morphine-6-glucuronide synthesis |
| 09/26/2002 | WO2002028917A3 Resin and its use in converting morphine to codeine |
| 09/26/2002 | US20020137760 Antipruritic |
| 09/12/2002 | WO2002070567A1 Novel compound, process for producing the same, and use thereof as support for solid-phase reaction |
| 09/12/2002 | WO2002070524A2 N-but-3-enyl norbuprenorphine and its use as analgesic |
| 09/12/2002 | CA2439859A1 N-but-3-enyl norbuprenorphine and its use as analgesic |
| 09/06/2002 | WO2002067916A2 Pharmaceutical salts |
| 09/06/2002 | WO2002067651A2 Pharmaceutical salts |
| 09/06/2002 | CA2725635A1 Pharmaceutical salts of 6-dimethylaminomethyl-1-phenylcyclohexane compounds |
| 09/05/2002 | DE10109763A1 Pharmazeutische Salze Pharmaceutical Salts |
| 09/04/2002 | CN1090190C Heterocycle-condensed morphinoid derivatives and its preparing method and use |
| 09/04/2002 | CN1090189C Pyrazolopyrimidines type compound |
| 08/29/2002 | WO2002066031A1 Utilization of buprenorphine in urinary incontinence therapy |
| 08/29/2002 | US20020119203 Preparing first phase comprising nucleophilic active agent, a polymer and solvent; combining with second phase in a static mixer to form emulsion; extracting solvent from the emulsion, thereby forming microparticles |
| 08/28/2002 | EP1233966A1 Hydromorphinone and hydrocodeinone compositions and methods for their synthesis |
| 08/27/2002 | US6440987 Antipruritic |
| 08/08/2002 | US20020106761 Production of thebaine and oripavine |
| 08/07/2002 | EP1227798A1 Controlled release hydrocodone formulations |
| 07/24/2002 | EP1224188A2 A salt of morphine |
| 07/03/2002 | EP1219624A1 Remedies for neuropathic pain and model animals of neuropathic pain |
| 06/27/2002 | US20020082357 Resin comprising a solid support and at least one cationic methylated sulfonium, sulfoxonium, selenonium or phosphonium salt immobilized on the solid support for use as methylating agent |
| 06/11/2002 | US6403798 Method for preparing oxycodone |
| 06/11/2002 | US6403602 Morphine-6-sulfate analogues and their use for the treatment of pain |
| 06/06/2002 | WO2002043713A2 Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence |
| 06/06/2002 | DE10059415A1 Verwendung von schwachen Opioiden und gemischten Opioidagonisten/-antagonisten zur Therapie der Harninkontinenz Use of weak opioids and mixed opioid agonist / antagonist for the treatment of urinary incontinence |
| 06/05/2002 | EP1210084A1 Pyridomorphinans, thienomoprhinans and use thereof |
| 05/28/2002 | US6395900 N-deprotection and/or o-demethylation of an opioid compound or of a nonpeptidic delta tert-amide agonist with a lithium trialkylborohydride |
| 05/15/2002 | EP1204414A2 Use of morphinan derivates as medicines |
| 05/15/2002 | EP1204406A2 Opioid sustained-released formulation |
| 05/14/2002 | US6387917 Nasal administering |
| 05/10/2002 | WO2002036573A2 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents |
| 05/10/2002 | WO2002036099A1 Controlled release hydrocodone formulations |
| 05/10/2002 | WO2001046198A3 Nonpeptide kappa opioid receptor antagonists |
| 05/08/2002 | EP1203771A1 Remedies or preventives for frequent urination or urinary incontinence |
| 05/02/2002 | WO2001042207A3 Novel methods for the treatment and prevention of ileus |
| 05/02/2002 | EP1200089A1 Pyridomorphinans and use thereof |
| 04/30/2002 | US6379704 Method for preparing microparticles having a selected polymer molecular weight |
| 04/23/2002 | US6376221 Harvesting poppy capsules of stably reproducing papaver somniferum to produce straw containing thebaine and oripavine in at least 50% by weight of alkaloid mixture formed, chemically extracting thebaine and/or oripavine |
| 04/18/2002 | WO2002030936A1 Pyrrole-condensed morphinoid derivatives |
| 04/18/2002 | WO2002030935A1 Morphinoid derivatives as delta-opioid agonists and antagonists |
| 04/18/2002 | US20020045755 N-deprotection and/or O-demethylation of an opioid compound or of a nonpeptidic delta tert-amide agonist with a lithium trialkylborohydride |
| 04/11/2002 | WO2002028917A2 Resin and its use in converting morphine to codeine |
| 04/10/2002 | EP0915884B1 Preparation of narcotic analgesics |
| 04/02/2002 | US6365742 Preparation of opiates, intermediates and uses of salts |
| 04/02/2002 | US6365594 As opioid agonists and antagonists and are useful as i.a. analgesics |
| 03/20/2002 | EP1017696B1 Acidic addition salts of morphine alkaloids and the application thereof |
| 03/19/2002 | US6359111 Useful in treating cancer, and in a method of imaging opioid receptors either inside or outside of the central nervous system |
| 03/07/2002 | WO2001029047A3 Method for preparing oxycodone |
| 03/06/2002 | EP1183027A1 Pharmaceutical formulations and methods comprising intranasal morphine |
| 02/28/2002 | WO2002016367A1 Chemical methods |
| 02/21/2002 | WO2001089482A3 Method for preparing microparticles having a selected polymer molecular weight |
| 02/13/2002 | EP0861250B1 Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase |